Verseon Presents Oral Drug Candidate for Diabetic Eye Disease That Could Replace Eye Injections

FREMONT, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/biotech?src=hash" target="_blank"gt;#biotechlt;/agt;--Verseon presented their first DME development candidate at ARVO 2019. The candidate could lead to a real alternative to current eye injections.

Full Story →